Nothing Special   »   [go: up one dir, main page]

AU2758288A - Synergistic combination of decarboxylase inhibitors and l- dopa pellets - Google Patents

Synergistic combination of decarboxylase inhibitors and l- dopa pellets

Info

Publication number
AU2758288A
AU2758288A AU27582/88A AU2758288A AU2758288A AU 2758288 A AU2758288 A AU 2758288A AU 27582/88 A AU27582/88 A AU 27582/88A AU 2758288 A AU2758288 A AU 2758288A AU 2758288 A AU2758288 A AU 2758288A
Authority
AU
Australia
Prior art keywords
synergistic combination
decarboxylase inhibitors
dopa
pellets
dopa pellets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU27582/88A
Other versions
AU611512B2 (en
Inventor
Manfred Albring
Helmut Hettche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asta Medica GmbH
Original Assignee
Asta Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6343914&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2758288(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Asta Pharma AG filed Critical Asta Pharma AG
Publication of AU2758288A publication Critical patent/AU2758288A/en
Application granted granted Critical
Publication of AU611512B2 publication Critical patent/AU611512B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrophonic Musical Instruments (AREA)
  • Lock And Its Accessories (AREA)

Abstract

A synergistic combination of L-dopa pellets and decarboxylase inhibitors as pharmaceuticals for Parkinson's disease.
AU27582/88A 1987-12-31 1988-12-30 Synergistic combination of decarboxylase inhibitors and l- dopa pellets Ceased AU611512B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3744646 1987-12-31
DE3744646 1987-12-31

Publications (2)

Publication Number Publication Date
AU2758288A true AU2758288A (en) 1989-07-06
AU611512B2 AU611512B2 (en) 1991-06-13

Family

ID=6343914

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27582/88A Ceased AU611512B2 (en) 1987-12-31 1988-12-30 Synergistic combination of decarboxylase inhibitors and l- dopa pellets

Country Status (13)

Country Link
EP (1) EP0324947B2 (en)
JP (1) JPH0296520A (en)
AT (1) ATE81971T1 (en)
AU (1) AU611512B2 (en)
CA (1) CA1315690C (en)
DE (1) DE3875716D1 (en)
DK (1) DK730488A (en)
ES (1) ES2052681T5 (en)
FI (1) FI886047A (en)
GR (2) GR3006182T3 (en)
IE (1) IE62643B1 (en)
NO (1) NO885820L (en)
PT (1) PT89350B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983400A (en) * 1986-06-16 1991-01-08 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
DE4101873C2 (en) 1991-01-23 1993-12-09 Isis Pharma Gmbh Orally administrable drug form for the treatment of central dopamine deficiency states
US8815950B2 (en) 2003-08-29 2014-08-26 Janssen Biotech, Inc. Pharmaceutical compositions and method of using levodopa and carbidopa
EP2508174A1 (en) 2011-04-06 2012-10-10 Ljiljana Sovic Brkicic Pharmaceutical composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3557292A (en) * 1968-08-16 1971-01-19 Hoffmann La Roche Compositions and methods for treating parkinson's disease with combinations of l-3,4-dihydroxyphenylalanine and a hydrazine
US3769424A (en) * 1970-10-01 1973-10-30 Merck & Co Inc Composition and method of treating dopamine deficiency in brain tissue
CH652025A5 (en) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmaceutical preparation.

Also Published As

Publication number Publication date
DK730488A (en) 1989-07-01
IE62643B1 (en) 1995-02-22
JPH0296520A (en) 1990-04-09
PT89350B (en) 1993-09-30
GR3006182T3 (en) 1993-06-21
ATE81971T1 (en) 1992-11-15
ES2052681T5 (en) 1997-12-01
FI886047A (en) 1989-07-01
NO885820L (en) 1989-07-03
ES2052681T3 (en) 1994-07-16
PT89350A (en) 1989-12-29
NO885820D0 (en) 1988-12-30
CA1315690C (en) 1993-04-06
EP0324947B1 (en) 1992-11-04
DE3875716D1 (en) 1992-12-10
AU611512B2 (en) 1991-06-13
IE883894L (en) 1989-06-30
DK730488D0 (en) 1988-12-30
GR3024980T3 (en) 1998-01-30
EP0324947A1 (en) 1989-07-26
EP0324947B2 (en) 1997-08-20

Similar Documents

Publication Publication Date Title
ZA907338B (en) Thienylcarboxylates of amino alcohols
BG47341A3 (en) Means for regulating plant growth
AU1994488A (en) Pharmaceutical therapeutic use of a glutathione derivative
HUT43952A (en) Process for preparing pharmaceuticals comprising (-)-3-(3,4-dihydroxyphenyl)-l-alanine-methylester
IL84425A (en) (s) - (+) -ibuprofen-containing pharmaceutical compositions
AU532114B2 (en) Salts of n-substituted-2-pyrrolidone-4-carboxylic acids
EP0345248A3 (en) Use of the enzyme-cofactor nadph in the preparation of a pharmaceutical, pharmaceutical and preparation thereof
HK217196A (en) Diamine salts of clavulanic acid
AU1706788A (en) 2-(3,4-dihydroxyphenyl)ethylamines, and their use pharmaceutical compositions
IL87566A0 (en) Medical composition for the treatment of diabetes comprising a benzamide derivative
AU2758288A (en) Synergistic combination of decarboxylase inhibitors and l- dopa pellets
AU3228489A (en) Treatment of equine livestock
AU4434389A (en) Aqueous oral pharmaceutical preparation of diclofenac
NZ223293A (en) Beta-alkyl melatonins and pharmaceutical compositions
AU4446889A (en) Ameliorating agent for dysmenesia
AU7071487A (en) Chlorpheniramine therapy
AU2143488A (en) Use of a compound for the treatment of sleep disorders and depression
GR3007079T3 (en)
AU3449389A (en) Procedure for improving the digestibility of animal feed and feed prepared according to the procedure
AU7025087A (en) Pharmaceutical compositions for the therapy of cerebropathies on functional and organic base
GR900300082T1 (en) Use of dapiprazole for the manufacture of a pharmaceutical composition inhibiting the development of tolerance in the analgesic treatment with morphine
GR3007110T3 (en)
AU4552489A (en) Amine salts of 1,4,2-oxazaphospholidine-4-acetic acid, 2-alkoxy-2-oxides
AU575892B2 (en) Tounge shaped pharmaceutical unit
NZ220242A (en) Regulating fertility in cattle by administering epostane